A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

NCT03607643 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer of Pancreas
Cancer of Liver
Cancer of Rectum
Cancer of Colon
Cancer, Gall Bladder
Myeloma Multiple
Glioblastoma Multiforme

Interventions

DRUG: Cannabidiol
DRUG: Bortezomib
DRUG: Leucovorin
DRUG: 5-FU
DRUG: Oxaliplatin
DRUG: Bevacizumab
DRUG: Irinotecan
DRUG: Gemcitabine
DRUG: Temozolomide

Sponsor

Leaf Vertical Inc.